Injectable Traction Therapy

Injectable Traction Therapy is a non-surgical treatment option for Peyronie's disease that aims to reduce penile curvature and improve sexual function. This innovative therapy involves the injection of medications directly into the affected area of the penis, combined with the application of traction or stretching forces.

During the procedure, a medical professional injects a medication, such as collagenase or Xiaflex®, into the plaque or scar tissue that causes the penile curvature in Peyronie's disease. The medication helps break down the fibrous tissue, making it more pliable. This is followed by the application of traction or stretching forces using a mechanical device or external stretching system. The combination of medication and traction helps to gradually stretch the affected tissue, promoting the remodeling of collagen and reducing the curvature of the penis. The therapy aims to improve penile straightness, restore sexual function, and alleviate associated symptoms, such as pain or discomfort during intercourse.

Injectable Traction Therapy is typically performed as an outpatient procedure and does not require general anaesthesia. The treatment sessions are usually spaced out over several weeks or months, allowing for gradual correction of the penile curvature. 
Injectable Traction Therapy for Peyronie's Disease offers several benefits as a non-surgical treatment approach. It provides a minimally invasive option for individuals with Peyronie's disease, eliminating the need for surgical intervention. By applying traction forces to the penis, the therapy aims to gradually reduce penile curvature, resulting in a straighter erection. This improvement in curvature can lead to enhanced sexual function, including reduced pain or discomfort during intercourse and increased sexual satisfaction. Injectable traction therapy also serves as a non-pharmaceutical alternative to oral medications, offering localised treatment directly at the site of the fibrous plaque. Furthermore, the procedure is performed on an outpatient basis, allowing patients to resume their daily activities with minimal downtime

 Injectable Traction Therapy may not be suitable for everyone with Peyronie's disease. The eligibility for this treatment option depends on various factors, including the severity of the curvature, the presence of other underlying conditions, and individual patient considerations. A thorough evaluation by a qualified healthcare professional is necessary to determine if this treatment is appropriate for you.

While Injectable Traction Therapy has shown promising results in some patients, it's important to have realistic expectations. The extent of curvature correction may vary from person to person, and additional treatments or therapies may be required to achieve optimal outcomes. If you are considering Injectable Traction Therapy for Peyronie's disease, it's crucial to consult with a qualified healthcare professional at MASSH. They can evaluate your individual case, discuss the potential benefits and risks, and guide you through the treatment process.